| Date | Name | Shares | Transaction | Value |
|
Dec 4, 2025
| David M. Schatz Sr. VP, Sec y & Gen. Counsel |
25,536
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $212.91 per share |
5,436,869.76
|
|
Dec 4, 2025
| Christopher L. Tucker Sr. Vice President & CFO |
18,978
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $212.91 per share |
4,040,605.98
|
|
Dec 4, 2025
| Bryan H. Sayler CEO & PRESIDENT; Director |
38,210
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $212.91 per share |
8,135,291.10
|
|
Dec 3, 2025
| Janice L. Hess Director |
5,623
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $204.97 per share |
1,152,546.31
|
|
Dec 3, 2025
| Janice L. Hess Director |
3,287
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Dec 3, 2025
| Janice L. Hess Director |
1,349
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 |
0.00
|
|
Nov 4, 2025
| Gloria L. Valdez Director |
2,131
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $219.47 per share |
467,690.57
|
|
Nov 4, 2025
| Gloria L. Valdez Director |
8,748
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Apr 18, 2025
| Vinod M. Khilnani Director |
1,348
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 18, 2025
| Robert J. Phillippy Director |
20,387
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 18, 2025
| David A. Campbell Director |
2,640
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 18, 2025
| Patrick M. Dewar Director |
22,639
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 18, 2025
| Penelope McLean-Conner Director |
2,053
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 6, 2025
| Leon J. Olivier Director |
11,992
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $132.16 per share |
1,584,862.72
|
|
Feb 6, 2025
| Leon J. Olivier Director |
25,049
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Feb 6, 2025
| Leon J. Olivier Director |
22,805
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 |
0.00
|